Advertisement

Reactions Weekly

, Volume 1738, Issue 1, pp 104–104 | Cite as

Deferasirox

Renal insufficiency and skin toxicity: 2 case report
Case report
  • 15 Downloads

Reference

  1. Di Veroli A, et al. Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?. Leukemia Research 76: 65-69, Jan 2019. Available from: URL: http://doi.org/10.1016/j.leukres.2018.11.012 - Italy

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations